An interactive guide to managing complications in achondroplasia

This interactive tool is based on guidance adapted from the International Consensus Statement—a publication developed by 55 specialists from 16 different countries to help standardize care for patients with achondroplasia, with sponsorship from BioMarin Pharmaceutical Inc.

Discover helpful guidance centering around diagnosis, multidisciplinary treatment, and lifelong care for individuals with achondroplasia, across each stage of life.

Review this tool in conjunction with the International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia

The initial meeting of experts was sponsored by BioMarin Pharmaceuticals Inc., who also provided logistic assistance. The International Consensus Statement publication was funded by BioMarin, but developed independently. The publication should be read in its entirety. This website does not provide medical advice and does not replace the need for independent research, medical judgment, or review and analysis of additional resources.

This interactive guide is intended for healthcare professionals only.

Graphics were developed by BioMarin based on the International Consensus Statement.